查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423668

2030 年體外心律調節器市場預測：按設備、應用、最終用戶和地區進行的全球分析

External Pacemaker Market Forecasts to 2030 - Global Analysis By Device (Single Chamber and Dual Chamber), By Application (Acute Myocardial Infarction, Bradycardia, Heart Block and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球體外心律調節器市場規模為 17.6 億美元，預測期內複合年成長率為 5.4%，到 2030 年將達到 25.4 億美元。

體外心律調節器是醫療設備，旨在透過向外部傳遞電脈衝來調節心律。它由連接到外部發生器的電極組成，該發生器發出受控的電訊號。該設備被放置在患者的胸部，並向心臟發送電脈衝，以解決異常心律，例如心搏過緩其他傳導異常，直到實施永久解決方案。

根據美國疾病管制與預防中心 (CDC) 的數據，大約每 40 秒就有一名美國心臟病發作。每年有 805,000 名美國人心臟病發作，其中 605,000 人是首次心臟病發作。

老年人口不斷增加

老年人通常會出現心率異常，例如心搏過緩或心臟傳導阻滯。隨著人口老化的擴大，需要起搏器介入的心臟病盛行率也在增加。在這些情況下，外部起搏器可作為臨時解決方案，在患者等待永久植入時提供即時心臟支持，或作為心臟手術後的臨時措施。此外，世界人口老化與起搏器需求增加直接相關，從而推動市場成長。

心律調節器高成本

儘管這些設備對於心臟管理至關重要，但它們的採購和維護成本都很高。先進的技術、材料和製造流程導致價格急劇上升。此外，某些地區的醫療保健預算限制和有限的保險覆蓋範圍造成了經濟障礙，阻礙患者獲得救生設備。

新興國家可支配所得增加

收入水準的提高使新興國家有可能購買先進的醫療保健服務和醫療設備，包括心律調節器。這增加了對心臟治療的需求並增加了獲得昂貴醫療技術的機會。負擔能力的提高鼓勵更多的人選擇起搏器植入和治療，從而推動市場成長。此外，醫療保健支出的增加和保險覆蓋範圍的擴大也有助於提高這些經濟體的普及並改善市場形勢。

與替代療法的競爭

藥物治療、改變生活方式和其他非侵入性心臟治療等替代療法是起搏器植入的治療方法療法。對於某些心臟疾病，出於對手術、設備依賴性和成本的擔憂，患者可能會在考慮起搏器之前選擇替代療法。此外，非侵入性手術的進步和替代療法的研究可能會提供可行的選擇，並立即減少對起搏器的需求。

COVID-19 的影響：

COVID-19 大流行對體外心律調節器市場產生了重大影響。醫療服務、選擇性手術和醫院就診的中斷導致非緊急治療的推遲，包括起搏器植入。供應鏈中斷和與流行病相關的醫療保健資源的優先順序影響了設備的可得性。患者不願就醫和住院也導致心律調節器手術減少，導致市場成長暫時下降。

預計在預測期內醫院部門將是最大的

在預測期內，醫院部門預計將是最大的。該醫院是心臟護理的主要中心，擁有專業的基礎設施和熟練的醫療專業人員，能夠診斷和治療需要外部起搏器的複雜心臟病。此外，由於需要即時進行心臟治療的患者大量湧入，這些設施是起搏器植入和管理的主要中心。該醫院的綜合醫療服務和專業心臟科鞏固了其作為體外起搏器市場最大貢獻者的地位。

預計心臟塊領域在預測期內複合年成長率最高

預計心臟傳導阻滯細分市場在預測期內將出現良好的成長率。這是由於心臟傳導阻滯的盛行率不斷增加，即心臟的電訊號被延遲或阻塞。在這種情況下，外部心律調節器是調節心律的重要臨時解決方案，有助於滿足不斷成長的需求。此外，技術進步和人們對心臟健康意識的提高預計將推動採用外部起搏器進行心臟傳導阻滯管理，從而刺激該領域的快速成長。

比最大的地區

由於其先進的醫療基礎設施、心臟病的高盛行率和高昂的醫療費用，北美預計將在體外起搏器市場中佔據最大的市場佔有率。此外，主要市場參與者的存在和廣泛的研發活動也有助於形成市場主導地位。此外，不斷增加的心臟治療技術進步舉措以及積極採用創新醫療解決方案的舉措正在加強北美在體外起搏器市場的主導地位。

複合年成長率最高的地區：

由於心臟病患病率上升和老年人口不斷增加，預計亞太地區外部起搏器市場將顯著成長。此外，醫療基礎設施的改善、先進醫療保健意識的提高以及可支配收入的增加正在推動體外起搏器的採用率。此外，與國際醫療設備製造商的合作夥伴關係以及政府的支持措施進一步推動了市場擴張，顯示亞太地區體外起搏器市場的成長前景顯著。

提供免費客製化

如果您訂閱此報告，我們將為您提供以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球外部心律調節器市場：依設備分類

  • 單室
  • 雙腔室

第6章全球體外心律調節器市場：依應用分類

  • 急性心肌梗塞
  • 心搏過緩
  • 心臟傳導阻滯
  • 術後護理
  • 心搏過速
  • 其他用途

第7章全球外部心律調節器市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診所
  • 家庭保健
  • 其他最終用戶

第8章全球外部心律調節器市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Cook Medical
  • Galix Biomedical Instrumentation
  • LivaNova Plc
  • Medtronic
  • Osypka Medical GmbH
  • Reka Health Pte Ltd.
  • Schiller AG
  • Shree Pacetronix Ltd.
  • Spacelabs Healthcare
  • ZOLL Medical Corporation
Product Code: SMRC24902

According to Stratistics MRC, the Global External Pacemaker Market is accounted for $1.76 billion in 2023 and is expected to reach $2.54 billion by 2030 growing at a CAGR of 5.4% during the forecast period. An external pacemaker is a medical device designed to regulate heart rhythm by delivering electrical impulses externally. It consists of electrodes connected to an external generator that emits controlled electrical signals. This device is placed on the patient's chest and transmits electrical pulses to the heart, addressing abnormal heart rhythms like bradycardia or other conduction abnormalities until a permanent solution is implemented.

According to the Centers for Disease Control and Prevention (CDC), approximately every 40 seconds an American will have a heart attack. Every year, 805,000 Americans have a heart attack, 605,000 of them for the first time.

Market Dynamics:

Driver:

Growing geriatric population

Elderly individuals commonly experience heart rhythm abnormalities like bradycardia or heart block. As the ageing demographic expands, there's a higher prevalence of cardiac conditions necessitating pacemaker intervention. External pacemakers serve as temporary solutions in these cases, providing immediate cardiac support while patients await permanent implantation or temporary measure post-cardiac procedures. Additionally, the rising ageing population worldwide directly correlates with an increased demand for external pacemakers, fostering market growth.

Restraint:

High cost of pacemakers

These devices are crucial for cardiac management, but they involve substantial expenses for both procurement and maintenance. The sophisticated technology, materials, and manufacturing processes contribute to elevated prices. Additionally, healthcare budget constraints and limited insurance coverage in certain regions create financial barriers, hindering patient access to these life-saving devices, which limits their accessibility to a broader population.

Opportunity:

Increasing disposable income in emerging economies

Due to the rise in income levels, emerging economies can afford advanced healthcare services and devices, including pacemakers. This leads to a higher demand for cardiac care and better access to expensive medical technologies. Improved affordability allows a larger segment of the population to opt for pacemaker implantations or treatments, boosting market growth. Moreover, increased healthcare spending and better insurance coverage contribute to expanded adoption rates, creating a favourable market landscape in these economies.

Threat:

Competition from alternative therapies

Alternative treatments like medication, lifestyle changes, or other non-invasive cardiac interventions present alternatives to pacemaker implantation. For certain cardiac conditions, patients might opt for alternative therapies before considering a pacemaker due to concerns about surgery, device dependency, or cost. Moreover, advancements in non-invasive procedures and research into alternative treatments offer viable options, potentially reducing the immediate need for pacemakers.

Covid-19 Impact:

The COVID-19 pandemic had a substantial impact on the external pacemaker market. Disruptions in healthcare services, elective procedures, and hospital visits led to deferred non-emergency treatments, including pacemaker implantations. Supply chain disruptions and the prioritisation of resources for pandemic-related care affected device availability. Patient reluctance to seek medical care and hospitalisations also contributed to reduced pacemaker procedures, resulting in a temporary decline in market growth.

The hospitals segment is expected to be the largest during the forecast period

During the forecast period, the hospitals segment is poised to dominate. Hospitals serve as primary centres for cardiac care, equipped with specialised infrastructure and skilled healthcare professionals capable of diagnosing and treating complex cardiac conditions requiring external pacemakers. Additionally, these facilities often witness a high influx of patients requiring immediate cardiac interventions, making them primary hubs for pacemaker implantations and management. The comprehensive healthcare services and specialised cardiology departments in hospitals solidify their position as the largest contributors to the external pacemaker market.

The heart block segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the heart block segment is anticipated to experience a lucrative growth rate. This is attributed to the increasing prevalence of heart block conditions, where the heart's electrical signals are delayed or obstructed. External pacemakers serve as essential temporary solutions for regulating the heart's rhythm in such cases, contributing to their heightened demand. Additionally, advancements in technology and a growing awareness of cardiac health are expected to drive the adoption of external pacemakers for heart block management, fueling the segment's rapid growth.

Region with largest share:

North America is positioned to secure the largest market share in the external pacemaker market owing to its advanced healthcare infrastructure, high prevalence of cardiac disorders, and substantial healthcare expenditure. Additionally, the presence of key market players and extensive research and development activities contribute to market dominance. Furthermore, increasing initiatives for technological advancements in cardiac care and a proactive approach to adopting innovative medical solutions reinforce North America's prominence in the external pacemaker market.

Region with highest CAGR:

The Asia-Pacific region is poised for significant growth in the external pacemaker market due to the region's rising prevalence of cardiac disorders and an expanding geriatric population. Additionally, improving healthcare infrastructure, growing awareness about advanced medical treatments, and rising disposable incomes contribute to higher adoption rates of external pacemakers. Moreover, collaborations with international medical device manufacturers and supportive government initiatives further drive market expansion, indicating substantial growth prospects for the Asia-Pacific External Pacemaker market.

Key players in the market

Some of the key players in External Pacemaker Market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardiac Science Corporation, Cook Medical, Galix Biomedical Instrumentation, LivaNova Plc, Medtronic, Osypka Medical GmbH, Reka Health Pte Ltd., Schiller AG, Shree Pacetronix Ltd., Spacelabs Healthcare and ZOLL Medical Corporation.

Key Developments:

In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius™ intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.

In July 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.

Devices Covered:

  • Single Chamber
  • Dual Chamber

Applications Covered:

  • Acute Myocardial Infarction
  • Bradycardia
  • Heart Block
  • Post-Operative Care
  • Tachycardia
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global External Pacemaker Market, By Device

  • 5.1 Introduction
  • 5.2 Single Chamber
  • 5.3 Dual Chamber

6 Global External Pacemaker Market, By Application

  • 6.1 Introduction
  • 6.2 Acute Myocardial Infarction
  • 6.3 Bradycardia
  • 6.4 Heart Block
  • 6.5 Post-Operative Care
  • 6.6 Tachycardia
  • 6.7 Other Applications

7 Global External Pacemaker Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Clinics
  • 7.5 Home Healthcare
  • 7.6 Other End Users

8 Global External Pacemaker Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Biotronik
  • 10.3 Boston Scientific Corporation
  • 10.4 Cardiac Science Corporation
  • 10.5 Cook Medical
  • 10.6 Galix Biomedical Instrumentation
  • 10.7 LivaNova Plc
  • 10.8 Medtronic
  • 10.9 Osypka Medical GmbH
  • 10.10 Reka Health Pte Ltd.
  • 10.11 Schiller AG
  • 10.12 Shree Pacetronix Ltd.
  • 10.13 Spacelabs Healthcare
  • 10.14 ZOLL Medical Corporation

List of Tables

  • Table 1 Global External Pacemaker Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 3 Global External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 4 Global External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 5 Global External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 7 Global External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 8 Global External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 9 Global External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 10 Global External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 11 Global External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 12 Global External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 14 Global External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 15 Global External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 16 Global External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 17 Global External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 20 North America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 21 North America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 22 North America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 North America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 24 North America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 25 North America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 26 North America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 27 North America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 28 North America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 North America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 North America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 31 North America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 32 North America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 33 North America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 34 North America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 37 Europe External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 38 Europe External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 39 Europe External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Europe External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 41 Europe External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 42 Europe External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 43 Europe External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 44 Europe External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 45 Europe External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 Europe External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 Europe External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Europe External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 49 Europe External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 50 Europe External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 51 Europe External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 54 Asia Pacific External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 55 Asia Pacific External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 56 Asia Pacific External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 57 Asia Pacific External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 58 Asia Pacific External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 59 Asia Pacific External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 60 Asia Pacific External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 61 Asia Pacific External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 62 Asia Pacific External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Asia Pacific External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Asia Pacific External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Asia Pacific External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 66 Asia Pacific External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 67 Asia Pacific External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 68 Asia Pacific External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 71 South America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 72 South America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 73 South America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 74 South America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 75 South America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 76 South America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 77 South America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 78 South America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 79 South America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 80 South America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 South America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 82 South America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 83 South America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 84 South America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 85 South America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 88 Middle East & Africa External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 89 Middle East & Africa External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 90 Middle East & Africa External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 Middle East & Africa External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 92 Middle East & Africa External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 93 Middle East & Africa External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 94 Middle East & Africa External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 95 Middle East & Africa External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 96 Middle East & Africa External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 Middle East & Africa External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 Middle East & Africa External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Middle East & Africa External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 100 Middle East & Africa External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 101 Middle East & Africa External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 102 Middle East & Africa External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)